Bunting A, Fawole A, Fernando J, Appleton N, King C, Textor L
J Subst Use Addict Treat. 2024; 168:209560.
PMID: 39505111
PMC: 11624107.
DOI: 10.1016/j.josat.2024.209560.
Jakubowski A, Singh-Tan S, Torres-Lockhart K, Lu T, Arnsten J, Southern W
J Gen Intern Med. 2024; 39(15):2961-2969.
PMID: 39136887
PMC: 11576704.
DOI: 10.1007/s11606-024-08837-0.
Fielman S, McNeely J, Fitzpatrick A, Kerensky T, Tomanovich M, Walley A
J Addict Med. 2024; 18(3):215-217.
PMID: 38498619
PMC: 11150093.
DOI: 10.1097/ADM.0000000000001295.
French R, Compton P, Clapp J, Buttenheim A, Schachter A, Uhley O
BMJ Open Qual. 2023; 12(4).
PMID: 38114244
DOI: 10.1136/bmjoq-2023-002420.
Calcaterra S, Saunders S, Grimm E, Maki-Gianani E, Keniston A, Wold A
J Gen Intern Med. 2023; 39(3):385-392.
PMID: 37715094
PMC: 10897082.
DOI: 10.1007/s11606-023-08411-0.
"I wouldn't need Narcan for myself, but I can have it for somebody else:" perceptions of harm reduction among hospitalized patients with OUD.
French R, Davis M, Aronowitz S, Crowe M, Abrams M, Edwards G
Addict Sci Clin Pract. 2023; 18(1):41.
PMID: 37355639
PMC: 10290347.
DOI: 10.1186/s13722-023-00395-w.
"We do it ourselves": strengths and opportunities for improving the practice of harm reduction.
Claborn K, Samora J, McCormick K, Whittfield Q, Courtois F, Lozada K
Harm Reduct J. 2023; 20(1):70.
PMID: 37296459
PMC: 10250854.
DOI: 10.1186/s12954-023-00809-7.
Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation.
Jakubowski A, Singh-Tan S, Torres-Lockhart K, Nahvi S, Stein M, Fox A
Addict Sci Clin Pract. 2023; 18(1):31.
PMID: 37198707
PMC: 10193697.
DOI: 10.1186/s13722-023-00386-x.
Association Between Hospital Adoption of an Emergency Department Treatment Pathway for Opioid Use Disorder and Patient Initiation of Buprenorphine After Discharge.
Solomon K, OConnor J, Gibbons J, Kilaru A, Feder K, Xue L
JAMA Health Forum. 2023; 4(3):e230245.
PMID: 36961457
PMC: 10313142.
DOI: 10.1001/jamahealthforum.2023.0245.
Methadone treatment and patient-directed hospital discharges among patients with opioid use disorder: Observations from general medicine services at an urban, safety-net hospital.
Tierney H, Rowe C, Coffa D, Sarnaik S, Coffin P, Snyder H
Drug Alcohol Depend Rep. 2023; 3:100066.
PMID: 36845982
PMC: 9949313.
DOI: 10.1016/j.dadr.2022.100066.
Hospitalist perspectives on buprenorphine treatment for inpatients with opioid use disorder.
Reed M, Murali V, Sarpoulaki N, Zavodnick J, Hom J, Rising K
Drug Alcohol Depend Rep. 2023; 5:100106.
PMID: 36844165
PMC: 9948932.
DOI: 10.1016/j.dadr.2022.100106.
Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder.
Thakrar A, Uritsky T, Christopher C, Winston A, Ronning K, Sigueza A
Addict Sci Clin Pract. 2023; 18(1):13.
PMID: 36829242
PMC: 9951406.
DOI: 10.1186/s13722-023-00368-z.
Addressing Substance Use and Misuse in East Texas: Stakeholder-Driven Needs and Priorities.
Tiruneh Y, Elliott K, Oyer L, Elueze E, Casanova V
Int J Environ Res Public Health. 2022; 19(22).
PMID: 36429934
PMC: 9690065.
DOI: 10.3390/ijerph192215215.
A Call to Action: Integration of Buprenorphine Prescribing Into the Care of Persons With Human Immunodeficiency Virus and Opioid Use Disorder.
Fujita A, Deanna Wilson J, Kennedy A
Open Forum Infect Dis. 2022; 9(8):ofac400.
PMID: 36039099
PMC: 9384664.
DOI: 10.1093/ofid/ofac400.
Management of opioid use disorder, opioid withdrawal, and opioid overdose prevention in hospitalized adults: A systematic review of existing guidelines.
Calcaterra S, Bottner R, Martin M, Englander H, Weinstein Z, Weimer M
J Hosp Med. 2022; 17(9):679-692.
PMID: 35880821
PMC: 9474657.
DOI: 10.1002/jhm.12908.
Implementation of a comprehensive hospitalist-led initiative to improve care for patients with opioid use disorder.
Clifton D, Ivey N, Poley S, ORegan A, Raman S, Frascino N
J Hosp Med. 2022; 17(6):427-436.
PMID: 35535562
PMC: 9321616.
DOI: 10.1002/jhm.12837.
A Taxonomy of Hospital-Based Addiction Care Models: a Scoping Review and Key Informant Interviews.
Englander H, Jones A, Krawczyk N, Patten A, Roberts T, Korthuis P
J Gen Intern Med. 2022; 37(11):2821-2833.
PMID: 35534663
PMC: 9411356.
DOI: 10.1007/s11606-022-07618-x.
Expanding the Team: Optimizing the Multidisciplinary Management of Drug Use-Associated Infective Endocarditis.
ODonnell M, Englander H, Strnad L, Bhamidipati C, Shalen E, Riquelme P
J Gen Intern Med. 2022; 37(4):935-939.
PMID: 35018563
PMC: 8904655.
DOI: 10.1007/s11606-021-07313-3.
Opioid Use Disorder Treatment Initiation and Continuation: a Qualitative Study of Patients Who Received Addiction Consultation and Hospital-Based Providers.
Calcaterra S, Lockhart S, Callister C, Hoover K, Binswanger I
J Gen Intern Med. 2022; 37(11):2786-2794.
PMID: 34981359
PMC: 8722657.
DOI: 10.1007/s11606-021-07305-3.
Simulating the impact of Addiction Consult Services in the context of drug supply contamination, hospitalizations, and drug-related mortality.
King C, Cook R, Wheelock H, Korthuis P, Leahy J, Goff A
Int J Drug Policy. 2021; 100:103525.
PMID: 34837879
PMC: 8810590.
DOI: 10.1016/j.drugpo.2021.103525.